Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.860 | 2.010 | 0.150 |
Stocks | 98.140 | 98.140 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 24.449 | 24.032 |
Price to Book | 4.683 | 4.517 |
Price to Sales | 2.842 | 3.291 |
Price to Cash Flow | 17.524 | 15.892 |
Dividend Yield | 1.160 | 1.221 |
5 Years Earnings Growth | 13.056 | 12.392 |
Name | Net % | Category Average |
---|---|---|
Technology | 32.220 | 26.687 |
Industrials | 26.530 | 11.873 |
Healthcare | 15.670 | 16.365 |
Consumer Cyclical | 9.750 | 12.488 |
Financial Services | 8.520 | 13.478 |
Communication Services | 3.070 | 7.955 |
Consumer Defensive | 2.800 | 8.048 |
Real Estate | 1.440 | 1.947 |
Number of long holdings: 84
Number of short holdings: 11
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft Corp | - | 5.35 | - | - | |
NVIDIA Corp | - | 3.79 | - | - | |
Alphabet Inc Class C | - | 3.01 | - | - | |
Apple Inc | - | 2.79 | - | - | |
Eli Lilly | US5324571083 | 2.54 | 735.54 | -2.69% | |
Novo Nordisk B | DK0062498333 | 2.45 | 850.6 | -2.58% | |
Broadcom Inc | - | 2.40 | - | - | |
Xylem | US98419M1009 | 2.13 | 137.21 | +0.90% | |
SAP | DE0007164600 | 2.12 | 170.720 | +1.29% | |
Edwards Lifesciences | US28176E1082 | 2.08 | 85.24 | +0.21% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SE0011309681 | 9.87B | 10.52 | 8.68 | 11.18 | ||
Sverige Selektiv A1 EUR | 2.54B | 5.32 | 8.74 | 11.56 | ||
Handelsbanken Sverige Selektiv A9 E | 2.54B | 5.55 | 9.72 | - | ||
Handelsbanken Multi Asset 100 A1 E | 2.5B | 7.81 | 4.13 | 8.91 | ||
Nordiska Smabolag A1 EUR | 2.2B | 6.32 | -4.20 | 9.53 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review